TrialHypertension (Dallas, Tex. : 1979)2021

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial.

Kaisa M Mäki-Petäjä et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.